Media stories about Varian Medical Systems (NYSE:VAR) have been trending somewhat positive this week, according to Accern Sentiment. Accern identifies positive and negative news coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Varian Medical Systems earned a media sentiment score of 0.20 on Accern’s scale. Accern also assigned media headlines about the medical equipment provider an impact score of 43.910838780495 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.
Here are some of the news stories that may have effected Accern Sentiment’s analysis:
- Varian Medical (VAR) Down 5.7% Since Earnings Report: Can It Rebound? (finance.yahoo.com)
- Varian (VAR) Acquires Evinance to Boost Oncology Segment (zacks.com)
- Insider Selling: Varian Medical Systems, Inc. (VAR) Director Sells 1,952 Shares of Stock (americanbankingnews.com)
- Varian Medical Systems (VAR) Buys Evinance Innovation (streetinsider.com)
- Varian ARIA Oncology Information System Earns ONC Health IT Certification from Drummond Group LLC (finance.yahoo.com)
Shares of Varian Medical Systems (NYSE VAR) traded up $1.39 during trading hours on Friday, reaching $121.17. The company had a trading volume of 317,080 shares, compared to its average volume of 987,211. Varian Medical Systems has a 52 week low of $83.20 and a 52 week high of $130.29. The stock has a market cap of $11,080.00, a P/E ratio of 33.20, a PEG ratio of 3.49 and a beta of 0.81.
A number of research analysts recently issued reports on VAR shares. Zacks Investment Research downgraded Varian Medical Systems from a “hold” rating to a “sell” rating in a report on Friday, October 27th. BTIG Research restated a “hold” rating on shares of Varian Medical Systems in a report on Sunday, October 29th. Citigroup boosted their price target on Varian Medical Systems from $119.00 to $121.00 and gave the company a “neutral” rating in a report on Monday, October 30th. Royal Bank of Canada set a $105.00 price target on Varian Medical Systems and gave the company a “hold” rating in a report on Thursday, November 30th. Finally, Evercore ISI started coverage on Varian Medical Systems in a report on Wednesday, January 3rd. They set an “underperform” rating and a $100.00 price target on the stock. Three research analysts have rated the stock with a sell rating, seven have given a hold rating and three have given a buy rating to the company’s stock. Varian Medical Systems presently has an average rating of “Hold” and an average target price of $108.44.
In other Varian Medical Systems news, insider Dow R. Wilson sold 88,766 shares of Varian Medical Systems stock in a transaction that occurred on Monday, December 18th. The stock was sold at an average price of $111.00, for a total transaction of $9,853,026.00. Following the sale, the insider now directly owns 155,542 shares of the company’s stock, valued at approximately $17,265,162. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Timothy E. Guertin sold 10,000 shares of Varian Medical Systems stock in a transaction that occurred on Tuesday, January 2nd. The shares were sold at an average price of $111.46, for a total value of $1,114,600.00. Following the sale, the director now directly owns 2,161 shares in the company, valued at $240,865.06. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 158,118 shares of company stock worth $18,121,721. Insiders own 0.78% of the company’s stock.
About Varian Medical Systems
Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.
Receive News & Ratings for Varian Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.